MaxCyte, Inc.
$4.11
24H
Market Cap
Volume
Supply
Price Chart
About MaxCyte, Inc. - MXCT.L
MaxCyte, Inc. is a global clinical-stage company focused on cell-based medicines and life sciences that provides cell engineering technology to pharmaceutical and biotechnology organizations. They offer tools and services for drug discovery, drug development, and cell therapy, including their proprietary flow electroporation technology which enables the engineering of a wide range of cells.
What are MaxCyte, Inc.'s core values and mission statement?
MaxCyte, Inc. is committed to driving the acceleration of the discovery, development, manufacturing, and commercialization of next-generation, cell-based medicines. Their mission is centered on enabling their partners to advance their products to the clinic and the market faster and with greater success by providing efficient and streamlined cell engineering solutions.
Who founded MaxCyte, Inc. and when?
MaxCyte, Inc. was founded by Douglas Doerfler in 1998.
Who leads MaxCyte, Inc.?
As of the latest available information before any recent updates, MaxCyte, Inc. was led by Doug Doerfler, who is the founder, President, and Chief Executive Officer of the company.
Where is MaxCyte, Inc. located, and what is its base country?
MaxCyte, Inc. is headquartered in Gaithersburg, Maryland, USA, which is also its base country.
On which exchanges is MaxCyte, Inc. traded?
MaxCyte, Inc. is traded on the Nasdaq stock exchange under the ticker symbol MXCT.
Historical data
MaxCyte, Inc. (MXCT) Price Live Data
The live price of MaxCyte, Inc. (MXCT) is $4.11, with a trading volume of 485 in the last 24 hours. Wrapstocks updates the MXCT price in real-time. MaxCyte, Inc. is down -2.58% in the last 24 hours. The company has a live market cap of $4,306,400.53 and a supply of 1,048,240 MXCT stocks.
MaxCyte, Inc. (MXCT) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 19 hours and 59 minutes.
